ArticleDigestive diseases and sciences2025
Global, Regional, and National Burden of Pancreatitis in Adults Aged 20-54 Years, 1990-2021: Insight from the Global Burden of Disease Study 2021.
Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPancreatitis is a significant global health concern, particularly among working-age adults, yet comprehensive evaluations are scarce.
methodsUsing Global Burden of Disease Study 2021 data, we assessed the prevalence, mortality, and disability-adjusted life years (DALYs) of pancreatitis in individuals aged 20-54 years across 204 countries from 1990 to 2021. Age-standardized rates (ASRs) and estimated annual percentage changes (EAPCs) were analyzed.
resultsGlobally, ASRs for prevalence, mortality, and DALYs declined from 1990 to 2021. The most pronounced decline occurred in prevalence (EAPC, - 1.1; 95% CI, - 1.2 to - 1.0), whereas mortality (EAPC, - 0.6; 95% CI, - 0.8 to - 0.5) and DALYs (EAPC, - 0.6; 95% CI, - 0.77 to - 0.5) showed only modest reductions. Regional disparities existed, with reductions in High-income Asia Pacific, East Asia, and Central Europe and rising trends in Eastern Europe and parts of Sub-Saharan Africa. In 2021, Eastern Europe had the highest prevalence (791.4 per 100,000), mortality (6.3 per 100,000) and DALYs (349.4 per 100,000) ASRs. At the national level, the Russian Federation reported the highest burden. Age-specific analyses revealed a peak in burden in middle adulthood, with males exhibiting higher rates. A nonlinear relationship with the Socio-Demographic Index (SDI) was observed, with burden peaking in middle-SDI regions. High alcohol consumption was a major risk factor, particularly in parts of Europe and Australasia.
conclusionsDespite overall declines, limited reductions in mortality and DALYs indicate little improvement in prognosis. Pancreatitis remains a major global health issue, particularly in regions like Eastern Europe, underscoring the need for better prevention and management.
Indexed as
Identifiers
40705245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.